Device / Technology News

RSS

$FDA clears Vexim's COHESION bone cement to treat vertebral compression fractures$

FDA clears Vexim's COHESION bone cement to treat vertebral compression fractures

Vexim, the specialist in medical instruments designed for the minimally invasive, anatomical treatment of vertebral compression fractures, today announced that it had been awarded FDA clearance for its new product COHESION, a bone cement for injection into the vertebra following minimally invasive spinal fracture anatomical restoration with the company's SpineJack® device or used in performing a conventional vertebroplasty.

4 Apr 2011

World Medical Device Organization achieves its 100th online course

WMDO, the leading global provider of innovative online training for medical device professionals, announced today that it has achieved its 100th online course.

4 Apr 2011

Study finds high utilization of CTC and Medicare coverage in recent years

Medicare coverage and nationwide utilization of computed tomographic colonography, commonly referred to as virtual colonoscopy, has tripled in recent years, according to a study in the April issue of the Journal of the American College of Radiology.

4 Apr 2011

Life Technologies launches new TaqMan Mutation Detection Assays

Life Technologies Corporation today announced the launch of its TaqMan Mutation Detection Assays -- highly sensitive and novel molecular analysis research tools with the precision to detect a single mutant molecule hiding in a background of 1 million normal copies.

4 Apr 2011

Non-invasive catheterization can lead to positive outcomes in elderly patients with stenosis

A major new study presented today at the yearly scientific meeting of the American College of Cardiology (ACC) in New Orleans shows conclusively that replacing defective aortic valves in elderly patients through non-invasive "catheterization" – rather than through much more invasive open-heart surgery – leads to significantly better outcomes.

4 Apr 2011

SMT announces $10.5 million financing to develop novel device for use in TAVI procedures

SMT Research and Development Ltd. of Herzliya Pituach, Israel announced today a significant investment by OrbiMed Advisors LLC. SMT is finalizing the development of a novel embolic protection device designed for use during Transcatheter Aortic Valve Implantation procedures.

4 Apr 2011

Positive results from Abbott's ABSORB device trial in coronary artery disease

Abbott today announced positive one-year results from 101 patients enrolled in the second phase of the ABSORB trial evaluating the world's first drug eluting Bioresorbable Vascular Scaffold for the treatment of coronary artery disease.

4 Apr 2011

Regado's REG1 system Phase 2b trial results presented at i2 Summit

Regado Biosciences, Inc., a privately held company pioneering the development of antithrombotic aptamers with active control agents, announced today the primary results of the RADAR Phase 2b clinical trial of the company's lead product, the anticoagulation system REG1, at the i2 Summit during the American College of Cardiology 2011 60th Annual Scientific Session & Expo in New Orleans, LA.

4 Apr 2011

ORFLO introduces new Moxi Z mini cell counter

ORFLO Technologies announced the international launch of Moxi Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.

4 Apr 2011

New heart valve procedure helpful for the elderly: Study

Researchers revealed this Sunday a new heart valve that can be implanted without surgery. The device may hold promise for tens of thousands of elderly patients who might not survive a standard valve-replacement operation.

3 Apr 2011

Two experts to comment on new transcatheter heart valve studies

New transcatheter heart valve studies will be presented at the American College of Cardiology meeting in New Orleans on April 3 and 4. The studies compare patient outcomes from minimally invasive catheter procedures with those from open-heart surgery.

2 Apr 2011

Transgenomic to present study results of high-sensitivity cancer mutation assays at AACR

Transgenomic, Inc. announced today that its scientists have completed studies employing the company's high-sensitivity cancer mutation assays using two proprietary technologies, Ice COLD-PCR and BLOCker-Sequencing. Results from these studies will be presented at the American Association for Cancer Research meeting in Orlando, Florida, April 2-6, 2011.

2 Apr 2011

VSP launches mobile version for members to access vision care information

VSP Vision Care today launched the mobile version of vsp.com that allows members to access their vision care information from anywhere. Using a smartphone device, VSP members have access to features including: find a doctor, check your benefits, access your vision card and browse the eyewear gallery.

2 Apr 2011

CDC reviews clinical data from patients treated with BIOPATCH Protective Disk with CHG

Ethicon, Inc., announced today that the CDC has reviewed clinical data from patients treated with BIOPATCH Protective Disk with CHG as part of its update to the 2002 guidelines for reducing risk of intravascular catheter-associated infections in the United States. In the new guidelines, use of a CHG sponge dressing is designated as a Category 1B recommendation.

2 Apr 2011

Men and women with stretch marks problem can benefit from laser treatment

Men and women of all sizes are plagued with dreaded stretch marks and the process of eliminating them is often confusing, time consuming and lacks results.

2 Apr 2011

Global Autism Alliance launches new Internet website for public

In celebration of World Autism Day, April 2, the Global Autism Alliance will launch its Internet website, www.GlobalAutismAlliance.com, and premiere a video co-produced by representatives from around the world.

2 Apr 2011

Oncologist issues 'Emergency Radiation Medical Handbook'

Quickly responding to international demand due to Japan's disabled nuclear power reactors, James W. Forsythe, M.D., H.M.D., has issued an "Emergency Radiation Medical Handbook" for use worldwide.

2 Apr 2011

PLC's RenalGuard System REMEDIAL II trial final results to be presented at ACC conference

PLC Systems Inc., a company focused on innovative medical device technologies, today reported that final results from the REMEDIAL II investigator-sponsored clinical trial of its RenalGuard System™ in Italy are scheduled to be presented at 11:57 a.m. CT on Monday, April 4, 2011, at the American College of Cardiology's 60th Annual Scientific Session & Expo in New Orleans, Louisiana. Additionally, PLC will be demonstrating RenalGuard at its booth at the conference.

2 Apr 2011

Elmhurst Memorial Healthcare chooses Merge Cardio, Merge Hemo for new facility

Merge Healthcare Incorporated, a global corporation dedicated to health IT interoperability solutions, today announced that Elmhurst Memorial Healthcare, a 600-physician healthcare system based in Elmhurst, Illinois, selected Merge Cardio and Merge Hemo for their new 259-bed hospital.

2 Apr 2011